Health Populi

MAY 20, 2021

Year-on-year, different spikes and ups-and-downs call out for special mention, such as: Pharma’s 13-point steep dive to 38% between 2017 and 2018, dramatically recovering by 9 points in the last year to 47% [with the wild card here of whether U.S. to approve Medicare’s negotiation of drug prices with pharmaceutical companies].

BioTech 310

BioTech Pharmaceuticals Leadership Medicare 310

Health Populi

MARCH 19, 2019

Payors have begun to recognize the value of nudging consumers toward over-the-counter products under Medicare Advantage plans. Some specific consumer health brands and categories were faster-growing than others: Garden of Life, Sambucol, Pedialyte, Nature’s Truth, among them.

BioTech 149

BioTech Life Science Leadership Medicare 149

Health Populi

MAY 14, 2018

Incentives for lowering list prices for medicines, such as FDA requiring that drug companies include list prices in ads and bringing more transparency to Medicare drug pricing and generic competition, and. ” These prescriptions for lower pharma costs contrast with what most U.S.

Pharmaceuticals 120

Pharmaceuticals Medicare Life Science BioTech 120